Your patient currently takes the meglitinide medication, repaglinide 3 times daily with meals. She reports that recently she has changed her diet and is now eating 4 times a day. Which statement below is most appropriate for the nurse to give this patient?

A. "Split your dose between meals 3 and 4 to make sure some medication is being taken when you eat": Repaglinide is a rapid-acting meglitinide that must be taken immediately before each meal. Splitting doses between meals is unsafe and can lead to hypoglycemia or inadequate glycemic control. B. "With the extra meal, you should begin taking an extra dose of medication": Repaglinide’s action is meal-dependent, meaning each dose should correspond to a carbohydrate-containing meal. Adding a dose with the additional meal maintains proper postprandial glucose control and prevents hyperglycemia, ensuring safe and effective therapy. C. "As long as you feel fine, the extra meal won't affect your medication": Blood glucose may rise with the extra meal if no additional repaglinide is taken. Relying on subjective feelings is unsafe because hyperglycemia may be asymptomatic initially. D. "Go back to eating 3 times a day for better sugar control": Restricting meals unnecessarily may reduce the patient’s dietary flexibility and quality of life. The safer approach is adjusting medication to match carbohydrate intake rather than restricting meals.